# EMCOR Group, Inc.: financial statements, quarterly

EME · NYSE · CIK 105634 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eme.md) · [Financials](/companies/eme/financials.md) · [Filings](/companies/eme/filings.md) · [Insiders](/companies/eme/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eme/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,439 d](/filings/0000105634-26-000025.md) | [3,432](/filings/0000105634-25-000029.md) | [3,667](/filings/0000105634-25-000046.md) | [3,697](/filings/0000105634-25-000078.md) | [3,770 d](/filings/0000105634-26-000025.md) | [3,867](/filings/0000105634-26-000046.md) | [4,304](/filings/0000105634-26-000110.md) | [4,302](/filings/0000105634-26-000130.md) | [4,513 d](/filings/0000105634-26-000025.md) | [4,628](/filings/0000105634-26-000046.md) | [5,155](/filings/0000105634-26-000110.md) | [5,542](/filings/0000105634-26-000130.md) |
| Cost of revenue | $m | [2,821 d](/filings/0000105634-26-000025.md) | [2,843](/filings/0000105634-25-000029.md) | [2,983](/filings/0000105634-25-000046.md) | [2,962](/filings/0000105634-25-000078.md) | [3,013 d](/filings/0000105634-26-000025.md) | [3,145](/filings/0000105634-26-000046.md) | [3,471](/filings/0000105634-26-000110.md) | [3,466](/filings/0000105634-26-000130.md) | [3,622 d](/filings/0000105634-26-000025.md) | [3,764](/filings/0000105634-26-000046.md) | [4,133](/filings/0000105634-26-000110.md) | [4,433](/filings/0000105634-26-000130.md) |
| Gross profit | $m | [618 d](/filings/0000105634-26-000025.md) | [589](/filings/0000105634-25-000029.md) | [684](/filings/0000105634-25-000046.md) | [735](/filings/0000105634-25-000078.md) | [757 d](/filings/0000105634-26-000025.md) | [723](/filings/0000105634-26-000046.md) | [834](/filings/0000105634-26-000110.md) | [835](/filings/0000105634-26-000130.md) | [891 d](/filings/0000105634-26-000025.md) | [864](/filings/0000105634-26-000046.md) | [1,022](/filings/0000105634-26-000110.md) | [1,108](/filings/0000105634-26-000130.md) |
| Selling, general and administrative | $m | [329 d](/filings/0000105634-26-000025.md) | [329](/filings/0000105634-25-000029.md) | [351](/filings/0000105634-25-000046.md) | [371](/filings/0000105634-25-000078.md) | [368 d](/filings/0000105634-26-000025.md) | [404](/filings/0000105634-26-000046.md) | [419](/filings/0000105634-26-000110.md) | [430](/filings/0000105634-26-000130.md) | [462 d](/filings/0000105634-26-000025.md) | [460](/filings/0000105634-26-000046.md) | [475](/filings/0000105634-26-000110.md) | [528](/filings/0000105634-26-000130.md) |
| Operating income | $m | [289 d](/filings/0000105634-26-000025.md) | [260](/filings/0000105634-25-000029.md) | [333](/filings/0000105634-25-000046.md) | [364](/filings/0000105634-25-000078.md) | [389 d](/filings/0000105634-26-000025.md) | [319](/filings/0000105634-26-000046.md) | [415](/filings/0000105634-26-000110.md) | [406](/filings/0000105634-26-000130.md) | [574 d](/filings/0000105634-26-000025.md) | [404](/filings/0000105634-26-000046.md) | [547](/filings/0000105634-26-000110.md) | [546](/filings/0000105634-26-000130.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [80.2 d](/filings/0000105634-26-000025.md) | [70.6](/filings/0000105634-25-000029.md) | [91.6](/filings/0000105634-25-000046.md) | [102](/filings/0000105634-25-000078.md) | [106 d](/filings/0000105634-26-000025.md) | [83.5](/filings/0000105634-26-000046.md) | [110](/filings/0000105634-26-000110.md) | [112](/filings/0000105634-26-000130.md) | [143 d](/filings/0000105634-26-000025.md) | [105](/filings/0000105634-26-000046.md) | [148](/filings/0000105634-26-000110.md) | [150](/filings/0000105634-26-000130.md) |
| Net income | $m | [212 d](/filings/0000105634-26-000025.md) | [197](/filings/0000105634-25-000029.md) | [248](/filings/0000105634-25-000046.md) | [270](/filings/0000105634-25-000078.md) | [292 d](/filings/0000105634-26-000025.md) | [241](/filings/0000105634-26-000046.md) | [302](/filings/0000105634-26-000110.md) | [295](/filings/0000105634-26-000130.md) | [435 d](/filings/0000105634-26-000025.md) | [305](/filings/0000105634-26-000046.md) | [404](/filings/0000105634-26-000110.md) | [400](/filings/0000105634-26-000130.md) |
| Diluted EPS | $ per share | not reported | [4.17](/filings/0000105634-25-000029.md) | [5.25](/filings/0000105634-25-000046.md) | [5.80](/filings/0000105634-25-000078.md) | not reported | [5.26](/filings/0000105634-26-000046.md) | [6.72](/filings/0000105634-26-000110.md) | [6.57](/filings/0000105634-26-000130.md) | not reported | [6.84](/filings/0000105634-26-000046.md) | [9.06](/filings/0000105634-26-000110.md) | [9.04](/filings/0000105634-26-000130.md) |
| Basic EPS | $ per share | not reported | [4.18](/filings/0000105634-25-000029.md) | [5.27](/filings/0000105634-25-000046.md) | [5.83](/filings/0000105634-25-000078.md) | not reported | [5.27](/filings/0000105634-26-000046.md) | [6.74](/filings/0000105634-26-000110.md) | [6.59](/filings/0000105634-26-000130.md) | not reported | [6.85](/filings/0000105634-26-000046.md) | [9.09](/filings/0000105634-26-000110.md) | [9.06](/filings/0000105634-26-000130.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0000105634-25-000015.md) | [0.8](/filings/0000105634-24-000013.md) | [0.8](/filings/0000105634-24-000029.md) | [1.0](/filings/0000105634-24-000037.md) | [1.3](/filings/0000105634-26-000025.md) | [0.6](/filings/0000105634-25-000029.md) | [0.5](/filings/0000105634-25-000046.md) | [0.7](/filings/0000105634-25-000078.md) | [1.1](/filings/0000105634-26-000130.md) | [0.9](/filings/0000105634-26-000046.md) | [0.9](/filings/0000105634-26-000110.md) | [0.8](/filings/0000105634-26-000130.md) |
| Current assets | $bn | [4.4](/filings/0000105634-25-000015.md) | [4.5](/filings/0000105634-24-000013.md) | [4.7](/filings/0000105634-24-000029.md) | [5.0](/filings/0000105634-24-000037.md) | [5.4](/filings/0000105634-26-000025.md) | [4.9](/filings/0000105634-25-000029.md) | [5.2](/filings/0000105634-25-000046.md) | [5.5](/filings/0000105634-25-000078.md) | [5.9](/filings/0000105634-26-000130.md) | [6.1](/filings/0000105634-26-000046.md) | [6.7](/filings/0000105634-26-000110.md) | [7.1](/filings/0000105634-26-000130.md) |
| Total assets | $bn | [6.6](/filings/0000105634-26-000025.md) | [6.7](/filings/0000105634-24-000013.md) | [7.1](/filings/0000105634-24-000029.md) | [7.3](/filings/0000105634-24-000037.md) | [7.7](/filings/0000105634-26-000025.md) | [8.1](/filings/0000105634-25-000029.md) | [8.4](/filings/0000105634-25-000046.md) | [8.6](/filings/0000105634-25-000078.md) | [9.3](/filings/0000105634-26-000130.md) | [9.5](/filings/0000105634-26-000046.md) | [10.2](/filings/0000105634-26-000110.md) | [11.2](/filings/0000105634-26-000130.md) |
| Current liabilities | $bn | [3.5](/filings/0000105634-25-000015.md) | [3.4](/filings/0000105634-24-000013.md) | [3.7](/filings/0000105634-24-000029.md) | [3.9](/filings/0000105634-24-000037.md) | [4.2](/filings/0000105634-26-000025.md) | [4.2](/filings/0000105634-25-000029.md) | [4.4](/filings/0000105634-25-000046.md) | [4.6](/filings/0000105634-25-000078.md) | [4.9](/filings/0000105634-26-000130.md) | [4.8](/filings/0000105634-26-000046.md) | [5.2](/filings/0000105634-26-000110.md) | [6.0](/filings/0000105634-26-000130.md) |
| Total liabilities | $bn | [4.1](/filings/0000105634-25-000015.md) | [4.1](/filings/0000105634-24-000013.md) | [4.3](/filings/0000105634-24-000029.md) | [4.6](/filings/0000105634-24-000037.md) | [4.8](/filings/0000105634-26-000025.md) | [5.1](/filings/0000105634-25-000029.md) | [5.3](/filings/0000105634-25-000046.md) | [5.3](/filings/0000105634-25-000078.md) | [5.6](/filings/0000105634-26-000130.md) | [5.6](/filings/0000105634-26-000046.md) | [6.1](/filings/0000105634-26-000110.md) | [7.0](/filings/0000105634-26-000130.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.5](/filings/0000105634-25-000015.md) | [2.6](/filings/0000105634-24-000013.md) | [2.7](/filings/0000105634-24-000029.md) | [2.8](/filings/0000105634-24-000037.md) | [2.9](/filings/0000105634-26-000025.md) | [2.9](/filings/0000105634-25-000029.md) | [3.1](/filings/0000105634-25-000046.md) | [3.3](/filings/0000105634-25-000078.md) | [3.7](/filings/0000105634-26-000130.md) | [3.9](/filings/0000105634-26-000046.md) | [4.1](/filings/0000105634-26-000110.md) | [4.3](/filings/0000105634-26-000130.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [424 d](/filings/0000105634-26-000025.md) | [132](/filings/0000105634-25-000029.md) | [280 d](/filings/0000105634-25-000046.md) | [526 d](/filings/0000105634-25-000078.md) | [469 d](/filings/0000105634-26-000025.md) | [108](/filings/0000105634-26-000046.md) | [194 d](/filings/0000105634-26-000110.md) | [476 d](/filings/0000105634-26-000130.md) | [524 d](/filings/0000105634-26-000025.md) | [0.6](/filings/0000105634-26-000046.md) | [289 d](/filings/0000105634-26-000110.md) | [797 d](/filings/0000105634-26-000130.md) |
| Capital expenditure | $m | [22.1 d](/filings/0000105634-26-000025.md) | [20.3](/filings/0000105634-25-000029.md) | [19.3](/filings/0000105634-25-000046.md) | [17.7](/filings/0000105634-25-000078.md) | [17.7 d](/filings/0000105634-26-000025.md) | [26.1](/filings/0000105634-26-000046.md) | [28.0](/filings/0000105634-25-000046.md) | [26.7](/filings/0000105634-25-000078.md) | [31.9 d](/filings/0000105634-26-000025.md) | [28.7](/filings/0000105634-26-000046.md) | [31.1 d](/filings/0000105634-26-000110.md) | [37.2 d](/filings/0000105634-26-000130.md) |
| Dividends paid | $m | [8.5 d](/filings/0000105634-26-000025.md) | [8.5](/filings/0000105634-25-000029.md) | [11.7 d](/filings/0000105634-25-000046.md) | [11.7 d](/filings/0000105634-25-000078.md) | [11.5 d](/filings/0000105634-26-000025.md) | [11.5](/filings/0000105634-26-000046.md) | [11.2 d](/filings/0000105634-26-000110.md) | [11.2 d](/filings/0000105634-26-000130.md) | [11.2 d](/filings/0000105634-26-000025.md) | [17.8](/filings/0000105634-26-000046.md) | [17.8 d](/filings/0000105634-26-000110.md) | [17.7 d](/filings/0000105634-26-000130.md) |
| Share repurchases | $m | [22.4 d](/filings/0000105634-26-000025.md) | [39.0](/filings/0000105634-25-000029.md) | [110 d](/filings/0000105634-25-000046.md) | [256 d](/filings/0000105634-25-000078.md) | [84.4 d](/filings/0000105634-26-000025.md) | [225](/filings/0000105634-26-000046.md) | [207 d](/filings/0000105634-26-000110.md) | [0.0 d](/filings/0000105634-26-000130.md) | [154 d](/filings/0000105634-26-000025.md) | [87.1](/filings/0000105634-26-000046.md) | [181 d](/filings/0000105634-26-000110.md) | [188 d](/filings/0000105634-26-000130.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.9](/filings/0000105634-24-000013.md) | [47.6](/filings/0000105634-24-000029.md) | [47.4](/filings/0000105634-24-000037.md) | [47.3](/filings/0000105634-25-000029.md) | [47.2](/filings/0000105634-25-000046.md) | [46.6](/filings/0000105634-25-000078.md) | [45.8](/filings/0000105634-26-000046.md) | [45.0](/filings/0000105634-26-000110.md) | [45.0](/filings/0000105634-26-000130.md) | [44.7](/filings/0000105634-26-000046.md) | [44.6](/filings/0000105634-26-000110.md) | [44.2](/filings/0000105634-26-000130.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 43,782,004 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0000105634-26-000130.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:33 ET. No prices; not investment advice.